Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing - 24/06/15
, Steve Rad, MD a, c, Sarah Beauchamp, RDMS c, Dalar Ratousi, MS c, Vaishnavi Subramaniam, MGC c, Sayeh Farivar, MS c, Margareta D. Pisarska, MD b, cAbstract |
Objective |
Since the introduction of noninvasive prenatal testing (NIPT), a marked decrease in prenatal diagnostic testing (chorionic villus sampling [CVS] and amniocentesis) has been observed with unknown potential effects on genetic diagnosis of these pregnancies. The purpose of this study was to understand the impact of NIPT on genetics counseling referrals, diagnostic testing with CVS/amniocentesis, and appropriate use of NIPT.
Study Design |
A retrospective cohort study was performed on all women referred for genetic counseling and prenatal testing during the 2 years preceding the introduction of NIPT (pre-NIPT) and 2 years following (post-NIPT). The primary outcome was the difference in the number of women referred for genetic counseling and prenatal diagnosis during the pre-NIPT period compared with the post-NIPT period. The secondary outcome was the difference in the number of women referred who were not considered candidates for NIPT between the 2 study periods.
Results |
There was a statistically significant reduction in the number of referrals for genetic counseling and diagnostic testing in the post-NIPT compared with the pre-NIPT period (2824 vs 3944, P = .001), a reduction of 28.4%. During the post-NIPT period there was a significant reduction in referrals of women who would not be candidates for NIPT (467 pre-NIPT vs 285 post-NIPT, P = .043). In women who had diagnostic testing with CVS during the study period, 32.4% of the aneuploidies identified would not have been detected by NIPT.
Conclusion |
There was a significant reduction in the number of patients referred for genetic counseling and prenatal diagnosis following the introduction of NIPT. In addition, there was a significant reduction in the number of patients referred for counseling and testing who would not be candidates for NIPT. This suggests that an increasing number of potential patients are being offered NIPT screening instead of diagnostic testing, including those at risk for fetal single gene disorders and aneuploidies not detectable by NIPT, potentially leading to misdiagnosis.
Le texte complet de cet article est disponible en PDF.Key words : amniocentesis, chorionic villus sampling, noninvasive prenatal testing, prenatal diagnosis
Plan
| J.W. is a member of the advisory panel for Natera Inc, San Carlos, CA. The remaining authors report no conflict of interest. |
|
| Cite this article as: Williams J, Rad S, Beauchamp S, et al. Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing. Am J Obstet Gynecol 2015;213:102.e1-6. |
Vol 213 - N° 1
P. 102.e1-102.e6 - juillet 2015 Retour au numéro
Article précédent
- Prospective evaluation of a protocol for using transabdominal ultrasound to screen for short cervix
- Santosh Pandipati, C. Andrew Combs, Alan Fishman, Sarah Y. Lee, Kimberly Mallory, Francesca Ianovich
- Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia
- Darcy R. Barry, Kristina M. Utzschneider, Jenny Tong, Kersten Gaba, Daniel F. Leotta, John D. Brunzell, Thomas R. Easterling
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?